Field of the Invention
The present invention relates to a fluid transfer device for a closed transfer of fluid from a medical device to a patient delivery device, such as an IV line or syringe. More specifically, the invention is directed to a fluid transfer device and packaging therefor configured for engaging/disengaging a connection element on the fluid transfer device using the packaging.
Description of Related Art
Healthcare workers, such as pharmacists and nurses, can be subject to acute and long term health risks upon repeated exposure to drugs or solvents which might escape into the air during drug preparation, drug administration, and other similar handling. This problem is particularly serious when cytotoxins, antiviral drugs, antibiotics, and radiopharmaceuticals are concerned. The health risks faced by exposure to these drugs can include the development of cancer, reproductive problems, genetic conditions, and other serious concerns. Other hazardous areas may be sample taking, such as samples concerning virus infections or the like. When performing infusions, it is often necessary to inject a drug or other medical substance into the infusion fluid, inside an infusion bag or other infusion fluid container. This is often done by means of penetrating a septum or other fluid barrier of an injection port on the infusion bag or on the infusion fluid line with a needle of a syringe filled with the medical fluid in question. However, even before this, it may be necessary to transfer the medical fluid from a vial to a syringe and then from the syringe to a secondary container. In each of these steps, staff may be exposed to the medical fluid by means of contamination. Such contamination may be vaporized medical fluid or aerosol in the air. The contaminations may contaminate the staff through their lungs, or by vaporized medical fluid or aerosol in the air which condensates on the skin to thereafter penetrate the skin of the staff. Some medicaments are even known to penetrate protection gloves and thereby contaminate the staff.
Exposure to contaminations like this may, on a long term basis, give rise to alarmingly high concentrations of medicaments in the blood or the human body of the staff as described above. It has been understood that, due to the many transferring steps between containers e.g., vials, syringes, infusion systems, etc., the risk for contamination during the actual insertion and retraction of a needle from the container, e.g., a vial, needs to be contained. Closed system transfer devices (CSTDs) have been developed to ensure that the medicament is contained in the transfer device during transfer of the medicament.
Generally, a CSTD includes an adapter for connection to a syringe and an adapter for connection to a vial, a second syringe, or a conduit providing fluid access to the patient's circulatory system. According to one arrangement, the healthcare practitioner may reconstitute a powdered or lyophilized compound with saline or some other reconstitution medium by attaching the syringe to the vial via connection of the respective adapters, reconstituting the drug, aspirating the compound into the syringe, disconnecting the adapters, and then attaching the syringe to the fluid conduit through the respective adapters to a patient delivery device, such as an IV line or syringe for administration to the patient.
One type of an adapter that can be used in a CSTD has a first connector having a male or female luer-lock element that is arranged to be joined with a corresponding female or male luer-lock element of a second connector component. According to one aspect, the second connector component can be a patient delivery device, such as an IV line or a syringe. The luer-lock element can, thus, be screwed into and unscrewed from the corresponding luer-lock element. It is desirable to prevent an accidental or inadvertent unscrewing of the components, which could lead to the disconnection of the fluid passage. Such disconnection may entail a serious contamination risk for a patient and/or any other person in the vicinity of the disconnected medical connector. The issue of safety in administration of hazardous medical compounds is one that has been identified as being of critical importance by professional organizations and government agencies alike.
It is, therefore, desirable to provide an adapter for enabling fluid transfer between the first connector and the second connector by facilitating a positive connection of the connectors and avoiding inadvertent or accidental disconnection of the connectors.
According to one aspect, a fluid transfer system may include a container and a connector. The container may include a tubular body having a sidewall extending between an open top end and a bottom end along a central axis to define an interior cavity. At least one protrusion may be aligned with the central axis and extend from an interior portion of the sidewall into the interior cavity. The connector may be configured for being received within the interior cavity of the container. The connector may include a body having a distal end, a proximal end, and a generally cylindrical sidewall extending between the distal end and the proximal end and defining a fluid passageway therethrough. An inner member may be provided at one of the distal end and the proximal end of the body, such that the inner member is configured to cooperate with a patient delivery device to provide fluid communication between the body and the patient delivery device. Additionally, an outer member may surround at least a portion of the inner member, such that the inner member is configured to rotate freely relative to the outer member. A locking arrangement may be provided on at least a portion of the inner member and be accessible through at least a portion of the outer member. The locking arrangement may be configured for cooperating with the at least one protrusion to prevent rotation of the inner member relative to the outer member.
The locking arrangement may be configured to engage the at least one protrusion to prevent rotation of the inner member relative to the outer member upon an application of a compressive force on the container.
In accordance with another aspect, the at least one protrusion may include a pair of protrusions oriented opposite from each other around a circumference of the container. The container may further include a pair of tabs extending radially outward from an outer portion of the sidewall opposite the protrusions. The protrusions may be configured to deflect radially inward in response to the compressive force directed to the tabs. The sidewall of the container may be inclined relative to the central axis such that the sidewall narrows radially inward from the open top end to the closed bottom end. The at least one protrusion may be substantially parallel to the central axis of the container.
In accordance with a further aspect, the connector may include at least one window recessed within the body of the connector in a longitudinal direction of the connector. The at least one window may be configured to receive the at least one protrusion of the container when the connector is inserted into the interior cavity to prevent rotation of the connector relative to the container. Each window may extend through the sidewall of the connector such that, when deflected by the compressive force, the at least one protrusion engages the locking mechanism to prevent rotation of the inner member relative to the outer member of the connector. The locking arrangement may include at least one tooth extending from an engagement surface of the locking arrangement. The engagement surface of the locking arrangement may be engaged by the at least one protrusion upon the application of the compressive force. The inner member may include a luer-lock fitting.
In accordance with yet another aspect, a container may be configured for engaging/disengaging a connector with a patient delivery device. The container may include a tubular body having a sidewall extending between an open top end and a bottom end along a central axis to define an interior cavity configured for receiving the connector therein. At least one protrusion may be aligned with the central axis and extend from an interior portion of the sidewall into the interior cavity. The at least one protrusion may be configured for aligning the connector and preventing rotation of the connector relative to the container. At least one tab may extend radially outward from an outer portion of the sidewall opposite the at least one protrusion. The at least one protrusion may be configured to deflect radially inward in response to a compressive force directed to the tab and engage a locking arrangement of the connector. The at least one protrusion may include a pair of protrusions oriented opposite from each other around a circumference of the container. The sidewall of the container may be inclined relative to the central axis such that the sidewall narrows radially inward from the open top end to the closed bottom end. The at least one protrusion may be substantially parallel to the central axis of the container.
In another aspect, a connection device may be configured for engaging/disengaging a connector with a patient delivery device. The connection device may have a flexible body having an arcuate shape, at least one tab provided on one end of the body, and an engagement structure provided on the at least one tab. The engagement structure may be configured for engaging a locking arrangement on the connector to prevent rotation of an inner member of the connector relative to an outer member of the connector upon the application of a compressive force on the at least one tab. The at least one tab may further include a finger engagement surface. The at least one tab may be connected to a flexible joint.
These and other features and characteristics of the present invention, as well as the methods of operation and functions of the related elements of structures and the combination of parts and economies of manufacture, will become more apparent upon consideration of the following description and the appended claims with reference to the accompanying drawings, all of which form a part of this specification, wherein like reference numerals designate corresponding parts in the various figures. It is to be expressly understood, however, that the drawings are for the purpose of illustration and description only and are not intended as a definition of the limits of the invention. As used in the specification and the claims, the singular form of “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise.
The illustrations generally show preferred and non-limiting aspects of the systems and methods of the present disclosure. While the descriptions present various aspects of the devices, it should not be interpreted in any way as limiting the disclosure. Furthermore, modifications, concepts, and applications of the disclosure's aspects are to be interpreted by those skilled in the art as being encompassed by, but not limited to, the illustrations and descriptions herein.
Further, for purposes of the description hereinafter, the terms “end”, “upper”, “lower”, “right”, “left”, “vertical”, “horizontal”, “top”, “bottom”, “lateral”, “longitudinal”, and derivatives thereof shall relate to the disclosure as it is oriented in the drawing figures. The term “proximal” refers to the direction toward the center or central region of the device. The term “distal” refers to the outward direction extending away from the central region of the device. However, it is to be understood that the disclosure may assume various alternative variations and step sequences, except where expressly specified to the contrary. It is also to be understood that the specific devices and processes illustrated in the attached drawings, and described in the following specification, are simply exemplary aspects of the disclosure. Hence, specific dimensions and other physical characteristics related to the aspects disclosed herein are not to be considered as limiting. For the purpose of facilitating understanding of the disclosure, the accompanying drawings and description illustrate preferred aspects thereof, from which the disclosure, various aspects of its structures, construction and method of operation, and many advantages may be understood and appreciated.
With reference to
A cap 16 (shown in
With reference to
The container 10 is sealed at the top end 22 by the cap 16. A lip 28 extends radially outward from the open top end 22 relative to the central axis 26. The lip 28 provides an interface for the engagement of the cap 16 with the container 10. The closed bottom end 24 may have a substantially flattened shape to enable the container 10 to be supported when the closed bottom end 24 is placed on a level surface. Alternatively, the closed bottom end 24 may have a rounded or arcuate shape, or a shape configured to correspond to a bottom end of the connector 12. The container 10 may be constructed from any known material, such as a molded, injected, or thermo-formed plastic material. Desirably, the container 10 is constructed from a material that provides flexibility of the sidewall 20 in at least the radial direction with respect to the central axis 26. In particular, the container 10 is desirably constructed from a material that allows the cross-sectional shape of the container 10 to change with an application of a radially-directed force, as will be described in greater detail hereinafter.
With reference to
With specific reference to
With specific reference to
With reference to
With continuing reference to
With reference to
With reference to
According to one aspect, as shown in
With reference to
With continued reference to
With reference to
With reference to
Having described the structure of the container 10 and the connector 12 disposed therein, a method of securing the connector 12 to the patient delivery device 48 using the container 10 will now be described. The method includes providing the container 10 and the connector 12, as described hereinabove. Desirably, the connector 12 is disposed entirely within the container 10 and sealed by the cap 16. After removing the cap 16, a radially-directed compressive force F is applied to the tabs 30 of the container 10, thereby causing compression of the container 10 and biasing of the protrusions 34 of the container 10 toward one another. The method further includes the engagement of the protrusions 34 with the locking arrangement 62 due to the radial deflection of the protrusions 34. As the protrusions 34 are deflected radially, the protrusions 34 are advanced through the window 70 and biased into engagement with the engagement surface 66 of the locking arrangement 62. Such engagement prevents free rotation of the inner member 46 relative to the outer member 54, thereby allowing the connection between the patient delivery device 48 and the inner member 46 of the connector 12. Although the protrusions 34 prevent rotation of the connector 12 within the container 10 while the patient delivery device 48 is secured to the inner member 46, any other portion of the connector 12 may interface with the container 10 to prevent relative rotation between the container 10 and the connector 12. In particular, the activation tab 72 of the connector 12 is received within the recess 32 of the container 10, which acts to prevent relative rotation between the container 10 and the connector 12 when the connector 12 is positioned within the container 10.
Upon release of the compressive force F, the protrusions 34 of the container 10 are disengaged from the locking arrangement 62 to permit free rotation of the inner member 46 relative to the outer member 54, thereby preventing inadvertent and/or accidental disconnection of the inner member 46 from the patient delivery device 48. The method can also include the re-application of the compressive force F to cause the locking arrangement 62 to be re-engaged for removal of the patient delivery device 48 from the connector 12.
With reference to
Referring to
In another aspect, the connection device 80 may be naturally biased to interface with the locking arrangement 62 without requiring the application of a radially-directed force F. In this aspect, the connection device 80 may be snap-fitted or clipped to the connector 12 such that the projections 88 are biased against the engagement surface 66 to prevent the rotation of the inner member 46 relative to the outer member 54. The connection device 80 is disengaged by unsnapping or unclipping the projections 88 with an application of a force directed in a radially-outward direction. The connection device 80 may be completely removable from the connector 12, or it may be formed integrally therewith such that the projections 88 can be disengaged from the engagement surface 66.
Although the invention has been described in detail for the purpose of illustration based on what is currently considered to be the most practical and preferred aspects, it is to be understood that such detail is solely for that purpose and that the invention is not limited to the disclosed aspects, but, on the contrary, is intended to cover modifications and equivalent arrangements that are within the spirit and scope of the appended claims. For example, it is to be understood that the present invention contemplates that, to the extent possible, one or more features of any aspect can be combined with one or more features of any other aspect.
This application claims priority to U.S. Provisional Application Ser. No. 61/982,049, filed Apr. 21, 2014, which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4436125 | Blenkush | Mar 1984 | A |
4564054 | Gustavsson | Jan 1986 | A |
4673404 | Gustavsson | Jun 1987 | A |
4932937 | Gustavsson et al. | Jun 1990 | A |
5052725 | Meyer et al. | Oct 1991 | A |
5104158 | Meyer et al. | Apr 1992 | A |
5122129 | Olson et al. | Jun 1992 | A |
5280876 | Atkins | Jan 1994 | A |
5290254 | Vaillancourt | Mar 1994 | A |
5322518 | Schneider et al. | Jun 1994 | A |
5334188 | Inoue et al. | Aug 1994 | A |
5360011 | McCallister | Nov 1994 | A |
5395348 | Ryan | Mar 1995 | A |
5437650 | Larkin et al. | Aug 1995 | A |
5464123 | Scarrow | Nov 1995 | A |
5472430 | Vaillancourt et al. | Dec 1995 | A |
5478328 | Silverman et al. | Dec 1995 | A |
5487728 | Vaillancourt | Jan 1996 | A |
5507733 | Larkin et al. | Apr 1996 | A |
5509911 | Cottone, Sr. et al. | Apr 1996 | A |
5545152 | Funderburk et al. | Aug 1996 | A |
5607392 | Kanner | Mar 1997 | A |
5609584 | Gettig et al. | Mar 1997 | A |
5611792 | Gustafsson | Mar 1997 | A |
5647845 | Haber et al. | Jul 1997 | A |
5685866 | Lopez | Nov 1997 | A |
5807347 | Bonaldo | Sep 1998 | A |
5897526 | Vaillancourt | Apr 1999 | A |
6063068 | Fowles et al. | May 2000 | A |
6089541 | Weinheimer et al. | Jul 2000 | A |
6113583 | Fowles et al. | Sep 2000 | A |
6132404 | Lopez | Oct 2000 | A |
6139534 | Niedospial, Jr. et al. | Oct 2000 | A |
6221041 | Russo | Apr 2001 | B1 |
6221056 | Silverman | Apr 2001 | B1 |
6343629 | Wessman et al. | Feb 2002 | B1 |
6358236 | DeFoggi et al. | Mar 2002 | B1 |
6378714 | Jansen et al. | Apr 2002 | B1 |
6409708 | Wessman | Jun 2002 | B1 |
6474375 | Spero et al. | Nov 2002 | B2 |
6478788 | Aneas | Nov 2002 | B1 |
6544246 | Niedospial, Jr. | Apr 2003 | B1 |
6551299 | Miyoshi et al. | Apr 2003 | B2 |
6585695 | Adair et al. | Jul 2003 | B1 |
6599273 | Lopez | Jul 2003 | B1 |
6610040 | Fowles et al. | Aug 2003 | B1 |
6629958 | Spinello | Oct 2003 | B1 |
6656433 | Sasso | Dec 2003 | B2 |
6715520 | Andreasson et al. | Apr 2004 | B2 |
6814726 | Lauer | Nov 2004 | B1 |
6852103 | Fowles et al. | Feb 2005 | B2 |
6875203 | Fowles et al. | Apr 2005 | B1 |
6875205 | Leinsing | Apr 2005 | B2 |
6911025 | Miyahara | Jun 2005 | B2 |
6997917 | Niedospial, Jr. et al. | Feb 2006 | B2 |
7040598 | Raybuck | May 2006 | B2 |
7083605 | Miyahara | Aug 2006 | B2 |
7097209 | Unger et al. | Aug 2006 | B2 |
7261707 | Frezza et al. | Aug 2007 | B2 |
7306584 | Wessman et al. | Dec 2007 | B2 |
7326194 | Zinger et al. | Feb 2008 | B2 |
7350535 | Liepold et al. | Apr 2008 | B2 |
7354427 | Fangrow | Apr 2008 | B2 |
7452349 | Miyahara | Nov 2008 | B2 |
7547300 | Fangrow | Jun 2009 | B2 |
7628772 | McConnell et al. | Dec 2009 | B2 |
7648491 | Rogers | Jan 2010 | B2 |
7658734 | Adair et al. | Feb 2010 | B2 |
7743799 | Mosler et al. | Jun 2010 | B2 |
7744581 | Wallen et al. | Jun 2010 | B2 |
7758560 | Connell et al. | Jul 2010 | B2 |
7803140 | Fangrow, Jr. | Sep 2010 | B2 |
7857805 | Raines | Dec 2010 | B2 |
7867215 | Akerlund et al. | Jan 2011 | B2 |
7879018 | Zinger et al. | Feb 2011 | B2 |
7900659 | Whitley et al. | Mar 2011 | B2 |
7927316 | Proulx et al. | Apr 2011 | B2 |
7942860 | Horppu | May 2011 | B2 |
7975733 | Horppu et al. | Jul 2011 | B2 |
8096525 | Ryan | Jan 2012 | B2 |
8122923 | Kraus et al. | Feb 2012 | B2 |
8123738 | Vaillancourt | Feb 2012 | B2 |
8137332 | Pipelka | Mar 2012 | B2 |
8167863 | Yow | May 2012 | B2 |
8177768 | Leinsing | May 2012 | B2 |
8196614 | Kriheli | Jun 2012 | B2 |
8206367 | Warren et al. | Jun 2012 | B2 |
8211069 | Fangrow, Jr. | Jul 2012 | B2 |
8225826 | Horppu et al. | Jul 2012 | B2 |
8226628 | Muramatsu et al. | Jul 2012 | B2 |
8257286 | Meyer et al. | Sep 2012 | B2 |
8267127 | Kriheli | Sep 2012 | B2 |
8277424 | Pan | Oct 2012 | B2 |
8317741 | Kraushaar | Nov 2012 | B2 |
8317743 | Denenburg | Nov 2012 | B2 |
8398607 | Fangrow, Jr. | Mar 2013 | B2 |
8403905 | Yow | Mar 2013 | B2 |
8425487 | Beiriger et al. | Apr 2013 | B2 |
8449521 | Thorne, Jr. et al. | May 2013 | B2 |
8454579 | Fangrow, Jr. | Jun 2013 | B2 |
20030070726 | Andreasson et al. | Apr 2003 | A1 |
20050065495 | Zambaux | Mar 2005 | A1 |
20050182383 | Wallen | Aug 2005 | A1 |
20050215976 | Wallen | Sep 2005 | A1 |
20060178638 | Reynolds | Aug 2006 | A1 |
20070079894 | Kraus et al. | Apr 2007 | A1 |
20080045919 | Jakob et al. | Feb 2008 | A1 |
20080287914 | Wyatt et al. | Nov 2008 | A1 |
20090159485 | Jakob et al. | Jun 2009 | A1 |
20100168638 | Korogi et al. | Jul 2010 | A1 |
20100179506 | Shemesh et al. | Jul 2010 | A1 |
20100217226 | Shemesh | Aug 2010 | A1 |
20110004183 | Carrez et al. | Jan 2011 | A1 |
20110062703 | Lopez et al. | Mar 2011 | A1 |
20110074148 | Imai | Mar 2011 | A1 |
20110106046 | Hiranuma et al. | May 2011 | A1 |
20110257621 | Fangrow | Oct 2011 | A1 |
20110291406 | Kraft et al. | Dec 2011 | A1 |
20120035580 | Fangrow | Feb 2012 | A1 |
20120046636 | Kriheli | Feb 2012 | A1 |
20120123381 | Kraus et al. | May 2012 | A1 |
20120192968 | Bonnal et al. | Aug 2012 | A1 |
20120192976 | Rahimy et al. | Aug 2012 | A1 |
20120203193 | Rogers | Aug 2012 | A1 |
20120265163 | Cheng et al. | Oct 2012 | A1 |
20120279884 | Tennican et al. | Nov 2012 | A1 |
20120316536 | Carrez et al. | Dec 2012 | A1 |
20130006211 | Takemoto | Jan 2013 | A1 |
20130012908 | Yeung | Jan 2013 | A1 |
20130066293 | Garfield | Mar 2013 | A1 |
20130072893 | Takemoto | Mar 2013 | A1 |
20130076019 | Takemoto | Mar 2013 | A1 |
20130079744 | Okiyama et al. | Mar 2013 | A1 |
Number | Date | Country |
---|---|---|
2462971 | Jun 2012 | EP |
0128490 | Apr 2001 | WO |
2005011781 | Feb 2005 | WO |
2006058435 | Jun 2006 | WO |
2006103074 | Oct 2006 | WO |
2009024807 | Feb 2009 | WO |
2009090627 | Jul 2009 | WO |
2011050333 | Apr 2011 | WO |
2011150037 | Dec 2011 | WO |
2012069401 | May 2012 | WO |
2012119225 | Sep 2012 | WO |
2012168235 | Dec 2012 | WO |
2013025946 | Feb 2013 | WO |
2013054323 | Apr 2013 | WO |
2013066779 | May 2013 | WO |
2013115730 | Aug 2013 | WO |
2013179596 | Dec 2013 | WO |
2014122643 | Aug 2014 | WO |
2014181320 | Nov 2014 | WO |
Number | Date | Country | |
---|---|---|---|
20150297455 A1 | Oct 2015 | US |
Number | Date | Country | |
---|---|---|---|
61982049 | Apr 2014 | US |